Citation Impact
Citing Papers
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Introduction of Clusterin Gene into Human Renal Cell Carcinoma Cells Enhances Their Resistance to Cytotoxic Chemotherapy through Inhibition of Apoptosis both in vitro and in vivo
2001
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma
2015
Clusterin Is a Secreted Marker for a Hypoxia-Inducible Factor-Independent Function of the von Hippel-Lindau Tumor Suppressor Protein
2006 StandoutNobel
Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors via Elevated Local Production of CCL2
2015
Molecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
2008 StandoutNobel
Prognostic factors and selection for clinical studies of patients with kidney cancer
2007
Oxidative stress marker 8-hydroxyguanosine is more highly expressed in prostate cancer than in benign prostatic hyperplasia
2018
Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.
2003
OVER EXPRESSION OF CLUSTERIN IS AN INDEPENDENT PROGNOSTIC FACTOR FOR NONPAPILLARY RENAL CELL CARCINOMA
2002
OVER EXPRESSION OF CLUSTERIN IS AN INDEPENDENT PROGNOSTIC FACTOR FOR NONPAPILLARY RENAL CELL CARCINOMA
2002
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis
2016
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Works of Takehiro Sejima being referenced
Prostatic ischemia induces ventral prostatic hyperplasia in the SHR
2013
Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma
2013
Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma
2012
Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH
2014
Expression of Bcl-2, p53 Oncoprotein, and Proliferating Cell Nuclear Antigen in Renal Cell Carcinoma
1999
The significant immunological characteristics of peripheral blood neutrophil-to-lymphocyte ratio and Fas ligand expression incidence in nephrectomized tumor in late recurrence from renal cell carcinoma
2011